Rocket Pharmaceuticals RCKT Q2 2025 earnings
Reported August 7, 2025 · Before market open
EPS-$0.59Miss by $0.02
Revenue estimate$4.4M
EPS estimate-$0.57
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$222.2K
EPS estimate$1.04
Versus estimates
Diluted EPS
Ask the moment Rocket Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Rocket Pharmaceuticals report Q2 2025 earnings?
- Rocket Pharmaceuticals (RCKT) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were Rocket Pharmaceuticals's Q2 2025 revenue and EPS?
- Rocket Pharmaceuticals reported eps of $-0.59 for Q2 2025.
- Did Rocket Pharmaceuticals beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.57 by $0.02.
- How did Rocket Pharmaceuticals's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 20.3% from $-0.74.
- Where can I find Rocket Pharmaceuticals's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-104996) directly on SEC EDGAR. The filing index links above go to sec.gov.